Last Updated: September 28 2022

Copper is an essential mineral for antioxidative enzymes in the human body. While vital, it appears to be sufficient in the human diet and water supply with little evidence concerning its usefulness as a supplement. Excess copper is involved in some cases of Alzheimer's.

Copper is most often used for


Copper is an essential trace mineral that is used in a variety of processes in the body. The major function for copper is in catalyzing oxidation-reduction (REDOX) reactions important for the activity of a number of enzymes. Although copper is essential to health, most Western diets meet the recommended intake, making supplementation unnecessary in most healthy individuals.

Cases where copper deficiency may occur include patients who have undergone gastric bypass as well as chronic users of proton pump inhibitors, both of which interfere with copper absorption. Also, high levels of zinc intake may increase production of a protein known as metallothionein that can bind copper and reduce its levels in the body.

Although the REDOX chemistry catalyzed by copper is essential for a number of immune functions, copper also may play a role in Alzheimer's disease. Copper levels generally rise in the body with age, but seem to rise more sharply in those with Alzheimer's. Moreover, copper levels have been linked to Alzheimer's symptom severity, leading some to suggest that a lower copper intake may benefit the elderly.

Dosage information

Supplementation of copper tends to be in the 1mg dosage, but at this moment in time there seems to be no major supplemental purpose of copper in any form. Doses of 1mg appear to be safe over the short term while higher doses should be avoided.

Join our supplement information course

Don't miss out on the latest research

1.^Subar AF1, Krebs-Smith SM, Cook A, Kahle LLDietary sources of nutrients among US adults, 1989 to 1991J Am Diet Assoc.(1998 May)
7.^Liochev SI1, Fridovich IMechanism of the peroxidase activity of Cu, Zn superoxide dismutaseFree Radic Biol Med.(2010 Jun 15)
8.^Tainer JA, Getzoff ED, Richardson JS, Richardson DCStructure and mechanism of copper, zinc superoxide dismutaseNature.(1983 Nov 17-23)
9.^Getzoff ED, Tainer JA, Weiner PK, Kollman PA, Richardson JS, Richardson DCElectrostatic recognition between superoxide and copper, zinc superoxide dismutaseNature.(1983 Nov 17-23)
10.^Liochev SI1, Fridovich ICO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2Proc Natl Acad Sci U S A.(2004 Jan 20)
12.^Medinas DB1, Cerchiaro G, Trindade DF, Augusto OThe carbonate radical and related oxidants derived from bicarbonate bufferIUBMB Life.(2007 Apr-May)
15.^Blakley BR, Hamilton DLThe effect of copper deficiency on the immune response in miceDrug Nutr Interact.(1987)
16.^Koller LD, Mulhern SA, Frankel NC, Steven MG, Williams JRImmune dysfunction in rats fed a diet deficient in copperAm J Clin Nutr.(1987 May)
17.^Percival SS1Copper and immunityAm J Clin Nutr.(1998 May)
18.^Williams DMCopper deficiency in humansSemin Hematol.(1983 Apr)
20.^Squitti R1, Siotto M2, Polimanti R3Low-copper diet as a preventive strategy for Alzheimer's diseaseNeurobiol Aging.(2014 Sep)
21.^Barnard ND1, Bush AI2, Ceccarelli A3, Cooper J4, de Jager CA5, Erickson KI6, Fraser G7, Kesler S8, Levin SM9, Lucey B10, Morris MC11, Squitti R12Dietary and lifestyle guidelines for the prevention of Alzheimer's diseaseNeurobiol Aging.(2014 Sep)
24.^Saltzman E1, Karl JPNutrient deficiencies after gastric bypass surgeryAnnu Rev Nutr.(2013)
25.^Kumar N1, McEvoy KM, Ahlskog JEMyelopathy due to copper deficiency following gastrointestinal surgeryArch Neurol.(2003 Dec)
26.^Plantone D1, Renna R2, Primiano G3, Shukralla A4, Koudriavtseva T2PPIs as possible risk factor for copper deficiency myelopathyJ Neurol Sci.(2015 Jan 12)
27.^Sakai N1, Shin T, Schuster R, Blanchard J, Lentsch AB, Johnson WT, Schuschke DAMarginal copper deficiency increases liver neutrophil accumulation after ischemia/reperfusion in ratsBiol Trace Elem Res.(2011 Jul)
28.^Li Y1, Wang L, Schuschke DA, Zhou Z, Saari JT, Kang YJMarginal dietary copper restriction induces cardiomyopathy in ratsJ Nutr.(2005 Sep)
29.^Wildman RE1, Hopkins R, Failla ML, Medeiros DMMarginal copper-restricted diets produce altered cardiac ultrastructure in the ratProc Soc Exp Biol Med.(1995 Oct)
31.^Schuschke LA1, Saari JT, Miller FN, Schuschke DAHemostatic mechanisms in marginally copper-deficient ratsJ Lab Clin Med.(1995 Jun)
32.^Schuschke DA1, Adeagbo AS, Patibandla PK, Egbuhuzo U, Fernandez-Botran R, Johnson WTCyclooxygenase-2 is upregulated in copper-deficient ratsInflammation.(2009 Oct)
33.^Lentsch AB1, Kato A, Saari JT, Schuschke DAAugmented metalloproteinase activity and acute lung injury in copper-deficient ratsAm J Physiol Lung Cell Mol Physiol.(2001 Aug)
34.^Schuschke DA1, Percival SS, Lominadze D, Saari JT, Lentsch ABTissue-specific ICAM-1 expression and neutrophil transmigration in the copper-deficient ratInflammation.(2002 Dec)
35.^Elsherif L1, Ortines RV, Saari JT, Kang YJCongestive heart failure in copper-deficient miceExp Biol Med (Maywood).(2003 Jul)
38.^Plantone D, Primiano G, Renna R, Restuccia D, Iorio R, Patanella KA, Ferilli MN, Servidei SCopper deficiency myelopathy: A report of two casesJ Spinal Cord Med.(2014 Oct 24)
40.^Kumar N1, Ahlskog JE, Klein CJ, Port JDImaging features of copper deficiency myelopathy: a study of 25 casesNeuroradiology.(2006 Feb)
41.^Imani S1, Moghaddam-Banaem L, Roudbar-Mohammadi S, Asghari-Jafarabadi MChanges in copper and zinc serum levels in women wearing a copper TCu-380A intrauterine deviceEur J Contracept Reprod Health Care.(2014 Feb)
42.^Rodrigues da Cunha AC1, Dorea JG, Cantuaria AAIntrauterine device and maternal copper metabolism during lactationContraception.(2001 Jan)
45.^Fields M, Craft N, Lewis C, Holbrook J, Rose A, Reiser S, Smith JCContrasting effects of the stomach and small intestine of rats on copper absorptionJ Nutr.(1986 Nov)
46.^Brewer GJRisks of copper and iron toxicity during aging in humansChem Res Toxicol.(2010 Feb 15)
47.^Hill GM, Brewer GJ, Juni JE, Prasad AS, Dick RDTreatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balanceAm J Med Sci.(1986 Dec)
48.^Murgia C1, Vespignani I, Cerase J, Nobili F, Perozzi GCloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cellsAm J Physiol.(1999 Dec)
50.^Arredondo M1, Muñoz P, Mura CV, Nùñez MTDMT1, a physiologically relevant apical Cu1+ transporter of intestinal cellsAm J Physiol Cell Physiol.(2003 Jun)
51.^Espinoza A1, Le Blanc S, Olivares M, Pizarro F, Ruz M, Arredondo MIron, copper, and zinc transport: inhibition of divalent metal transporter 1 (DMT1) and human copper transporter 1 (hCTR1) by shRNABiol Trace Elem Res.(2012 May)
52.^Gao S1, Yin T2, Xu B2, Ma Y2, Hu M2Amino acid facilitates absorption of copper in the Caco-2 cell culture modelLife Sci.(2014 Jul 25)
53.^Wapnir RACopper absorption and bioavailabilityAm J Clin Nutr.(1998 May)
54.^Turnlund JR, King JC, Gong B, Keyes WR, Michel MCA stable isotope study of copper absorption in young men: effect of phytate and alpha-celluloseAm J Clin Nutr.(1985 Jul)
56.^Fischer PW, Giroux A, L'Abbé MRThe effect of dietary zinc on intestinal copper absorptionAm J Clin Nutr.(1981 Sep)
57.^Kumar KS1, Dayananda S, Subramanyam CCopper alone, but not oxidative stress, induces copper-metallothionein gene in Neurospora crassaFEMS Microbiol Lett.(2005 Jan 1)
61.^Sandstead HHCopper bioavailability and requirementsAm J Clin Nutr.(1982 Apr)
63.^Ferenci PWilson's diseaseClin Liver Dis.(1998 Feb)
64.^Brewer GJ1, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MTTreatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientineTransl Res.(2009 Aug)
65.^Yüce A1, Koçak N, Ozen H, Gürakan FWilson's disease patients with normal ceruloplasmin levelsTurk J Pediatr.(1999 Jan-Mar)
66.^Squitti R1, Ghidoni R, Scrascia F, Benussi L, Panetta V, Pasqualetti P, Moffa F, Bernardini S, Ventriglia M, Binetti G, Rossini PMFree copper distinguishes mild cognitive impairment subjects from healthy elderly individualsJ Alzheimers Dis.(2011)
67.^Squitti R1, Polimanti RCopper phenotype in Alzheimer's disease: dissecting the pathwayAm J Neurodegener Dis.(2013 Jun 21)
68.^Linder MC1, Hazegh-Azam MCopper biochemistry and molecular biologyAm J Clin Nutr.(1996 May)
69.^Hassan W1, Silva CE2, Mohammadzai IU3, da Rocha JB4, J LF2Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventionsCurr Neuropharmacol.(2014 Mar)
72.^Kalueff AV1, Nutt DJRole of GABA in anxiety and depressionDepress Anxiety.(2007)
74.^Russo AJ1Decreased zinc and increased copper in individuals with anxietyNutr Metab Insights.(2011 Feb 7)
75.^Schlegel-Zawadzka M1, Zieba A, Dudek D, Zak-Knapik J, Nowak GIs serum copper a "trait marker" of unipolar depression? A preliminary clinical studyPol J Pharmacol.(1999 Nov-Dec)
80.^Allen KG, Klevay LMCopper: an antioxidant nutrient for cardiovascular healthCurr Opin Lipidol.(1994 Feb)
81.^Reunanen A, Knekt P, Aaran RKSerum ceruloplasmin level and the risk of myocardial infarction and strokeAm J Epidemiol.(1992 Nov 1)
83.^Cooper GJ, Young AA, Gamble GD, Occleshaw CJ, Dissanayake AM, Cowan BR, Brunton DH, Baker JR, Phillips AR, Frampton CM, Poppitt SD, Doughty RNA copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled studyDiabetologia.(2009 Apr)
86.^Vaughan DEPAI-1 and atherothrombosisJ Thromb Haemost.(2005 Aug)
87.^Bügel S, Harper A, Rock E, O'Connor JM, Bonham MP, Strain JJEffect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy womenBr J Nutr.(2005 Aug)
88.^Bagheri B, Akbari N, Tabiban S, Habibi V, Mokhberi VSerum level of copper in patients with coronary artery diseaseNiger Med J.(2015 Jan-Feb)
90.^Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher RAnti-oxidant status and lipid peroxidation in patients with essential hypertensionJ Hypertens.(1998 Sep)
92.^Rojas-Sobarzo L, Olivares M, Brito A, Suazo M, Araya M, Pizarro FCopper supplementation at 8 mg neither affects circulating lipids nor liver function in apparently healthy Chilean menBiol Trace Elem Res.(2013 Dec)
93.^Turley E, McKeown A, Bonham MP, O'Connor JM, Chopra M, Harvey LJ, Majsak-Newman G, Fairweather-Tait SJ, Bügel S, Sandström B, Rock E, Mazur A, Rayssiguier Y, Strain JJCopper supplementation in humans does not affect the susceptibility of low density lipoprotein to in vitro induced oxidation (FOODCUE project)Free Radic Biol Med.(2000 Dec)
95.^Kazi TG1, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GACopper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patientsBiol Trace Elem Res.(2008 Apr)
96.^Ekmekcioglu C1, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl WConcentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controlsBiol Trace Elem Res.(2001 Mar)
97.^Walter RM Jr1, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CLCopper, zinc, manganese, and magnesium status and complications of diabetes mellitusDiabetes Care.(1991 Nov)
98.^Savu O1, Ionescu-Tirgoviste C, Atanasiu V, Gaman L, Papacocea R, Stoian IIncrease in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitusJ Int Med Res.(2012)
99.^Aguilar MV1, Saavedra P, Arrieta FJ, Mateos CJ, González MJ, Meseguer I, Martínez-Para MCPlasma mineral content in type-2 diabetic patients and their association with the metabolic syndromeAnn Nutr Metab.(2007)
100.^Williams NR1, Rajput-Williams J, West JA, Nigdikar SV, Foote JW, Howard ANPlasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitusAnalyst.(1995 Mar)
102.^Wills NK1, Ramanujam VM, Kalariya N, Lewis JR, van Kuijk FJCopper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and genderExp Eye Res.(2008 Aug)
103.^Behndig A1, Svensson B, Marklund SL, Karlsson KSuperoxide dismutase isoenzymes in the human eyeInvest Ophthalmol Vis Sci.(1998 Mar)
104.^Gahlot DK, Ratnakar KSEffect of experimentally induced chronic copper toxicity on retinaIndian J Ophthalmol.(1981 Dec)
105.^Wills NK1, Ramanujam VM, Chang J, Kalariya N, Lewis JR, Weng TX, van Kuijk FJCadmium accumulation in the human retina: effects of age, gender, and cellular toxicityExp Eye Res.(2008 Jan)
106.^Zampatti S1, Ricci F2, Cusumano A2, Marsella LT1, Novelli G3, Giardina E4Review of nutrient actions on age-related macular degenerationNutr Res.(2014 Feb)
107.^Age-Related Eye Disease Study Research GroupThe Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1Control Clin Trials.(1999 Dec)
110.^Gordon SA1, Lominadze D, Saari JT, Lentsch AB, Schuschke DAImpaired deformability of copper-deficient neutrophilsExp Biol Med (Maywood).(2005 Sep)
111.^Lominadze D1, Saari JT, Percival SS, Schuschke DAProinflammatory effects of copper deficiency on neutrophils and lung endothelial cellsImmunol Cell Biol.(2004 Jun)
116.^White C1, Lee J, Kambe T, Fritsche K, Petris MJA role for the ATP7A copper-transporting ATPase in macrophage bactericidal activityJ Biol Chem.(2009 Dec 4)
117.^Pyo HK1, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KHThe effect of tripeptide-copper complex on human hair growth in vitroArch Pharm Res.(2007 Jul)
118.^Kil MS, Kim CW, Kim SSAnalysis of serum zinc and copper concentrations in hair lossAnn Dermatol.(2013 Nov)
119.^Bhat YJ1, Manzoor S, Khan AR, Qayoom STrace element levels in alopecia areataIndian J Dermatol Venereol Leprol.(2009 Jan-Feb)
120.^Ozturk P1, Kurutas E2, Ataseven A3, Dokur N4, Gumusalan Y5, Gorur A6, Tamer L7, Inaloz S8BMI and levels of zinc, copper in hair, serum and urine of Turkish male patients with androgenetic alopeciaJ Trace Elem Med Biol.(2014 Jul)
121.^Turok DK1, Jacobson JC2, Dermish AI2, Simonsen SE3, Gurtcheff S4, McFadden M5, Murphy PA6Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy ratesContraception.(2014 Mar)
125.^Sivin I1, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR Jr, Lacarra M, McCarthy T, Holma P, et alRates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devicesAm J Obstet Gynecol.(1992 Apr)
126.^Godfrey EM1, Folger SG, Jeng G, Jamieson DJ, Curtis KMTreatment of bleeding irregularities in women with copper-containing IUDs: a systematic reviewContraception.(2013 May)
127.^Bush AI1, Tanzi RETherapeutics for Alzheimer's disease based on the metal hypothesisNeurotherapeutics.(2008 Jul)
128.^Bucossi S1, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti RCopper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studiesJ Alzheimers Dis.(2011)
130.^Madarić A1, Ginter E, Kadrabová JSerum copper, zinc and copper/zinc ratio in males: influence of agingPhysiol Res.(1994)
131.^Vasudevaraju P1, Bharathi, T J, Shamasundar NM, Subba Rao K, Balaraj BM, Ksj R, T S SRNew evidence on iron, copper accumulation and zinc depletion and its correlation with DNA integrity in aging human brain regionsIndian J Psychiatry.(2010 Apr)
132.^Mao X1, Ye J, Zhou S, Pi R, Dou J, Zang L, Chen X, Chao X, Li W, Liu M, Liu PThe effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused ratsNeurosci Lett.(2012 Jun 14)
133.^Ceccom J1, Coslédan F, Halley H, Francès B, Lassalle JM, Meunier BCopper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse modelPLoS One.(2012)
134.^White AR1, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai RThe Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal culturesJ Neurosci.(1999 Nov 1)
136.^Yoshiike Y1, Tanemura K, Murayama O, Akagi T, Murayama M, Sato S, Sun X, Tanaka N, Takashima ANew insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicityJ Biol Chem.(2001 Aug 24)
137.^Huang X1, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AIThe A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reductionBiochemistry.(1999 Jun 15)
139.^Huang X1, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, Scarpa RC, Saunders AJ, Lim J, Moir RD, Glabe C, Bowden EF, Masters CL, Fairlie DP, Tanzi RE, Bush AICu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reductionJ Biol Chem.(1999 Dec 24)
140.^Barnham KJ1, Masters CL, Bush AINeurodegenerative diseases and oxidative stressNat Rev Drug Discov.(2004 Mar)
141.^Dai XL1, Sun YX, Jiang ZFCu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structureActa Biochim Biophys Sin (Shanghai).(2006 Nov)
143.^Squitti R1, Polimanti R, Bucossi S, Ventriglia M, Mariani S, Manfellotto D, Vernieri F, Cassetta E, Ursini F, Rossini PMLinkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's diseaseRejuvenation Res.(2013 Feb)
144.^Aschner M1, West AKThe role of MT in neurological disordersJ Alzheimers Dis.(2005 Nov)
145.^Sharma S1, Ebadi M2Significance of metallothioneins in aging brainNeurochem Int.(2014 Jan)
147.^Heuchel R1, Radtke F, Georgiev O, Stark G, Aguet M, Schaffner WThe transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expressionEMBO J.(1994 Jun 15)
148.^Klaassen CD1, Liu J, Choudhuri SMetallothionein: an intracellular protein to protect against cadmium toxicityAnnu Rev Pharmacol Toxicol.(1999)
149.^Aschner M1, Syversen T, Souza DO, Rocha JBMetallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicityExp Biol Med (Maywood).(2006 Oct)
150.^Willis MS1, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, Bhushan V, Kroft SHZinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examinationAm J Clin Pathol.(2005 Jan)
152.^Nations SP1, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, Hynan LS, Reisch J, Trivedi JRDenture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic diseaseNeurology.(2008 Aug 26)
153.^Prodan CI1, Holland NR, Wisdom PJ, Burstein SA, Bottomley SSCNS demyelination associated with copper deficiency and hyperzincemiaNeurology.(2002 Nov 12)
154.^Prodan CI1, Holland NRCNS demyelination from zinc toxicityNeurology.(2000 Apr 25)
157.^Van Campen D, Gross EInfluence of ascorbic acid on the absorption of copper by ratsJ Nutr.(1968 Aug)